RTW Biotech Opportunities Ltd
Research RTW Biotech Opportunities Ltd (RTW) on Bullrun: market cap USD 756.96M, P/E 1.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRTW
- ExchangeLSE
- CountryGuernsey
- SectorFinancial Services
- IndustryAsset Management
- CurrencyUSD
- Market capUSD 756.96M
- P/E1.9
- Financial periodFY2025
- RevenueUSD 250.89M
- Revenue growth547.8%
- Net incomeUSD 245.19M
- Free cash flowUSD 105.25M
Valuation Snapshot
latest market cap is USD 756.96M; P/E is 1.9.
Peer valuation comparison
Latest P/E is 1.91x versus a Financial Services sector median of 13.04x (85.4% below).
Latest P/E is 1.91x versus a Guernsey median of 7.58x (74.8% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 250.89M | USD 245.19M | USD 105.25M | n/a | 0.63 | USD 5.99M | n/a | USD 865.22M |
| FY2024 | USD 38.73M | USD 34.18M | -USD 124.34M | n/a | 0.11 | USD 5.36M | n/a | USD 632.64M |
| FY2023 | USD 86.30M | USD 83.19M | USD 33.54M | n/a | 0.36 | USD 2.72M | n/a | USD 429.02M |
| FY2022 | -USD 36.51M | -USD 39.44M | USD 10.35M | n/a | -0.17 | USD 6.97M | n/a | USD 347.92M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-28 | USD 756.96M | 1.9 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 USD.
About RTW Biotech Opportunities Ltd
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is RTW Biotech Opportunities Ltd's market cap?
RTW Biotech Opportunities Ltd's market capitalization is USD 756.96M.
What is RTW Biotech Opportunities Ltd's P/E ratio?
RTW Biotech Opportunities Ltd's price-to-earnings (P/E) ratio is 1.9.
What does RTW Biotech Opportunities Ltd do?
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.